"Stemtech's Annual Incentive Cruise Sets Sail With Top Earners on Board; Colombia Pre-Registration Now Open and Product Expansion Unveiled for Ecuador" - Seite 2

Celebrating Top Producers:

In tandem with its strategic market moves, Stemtech is excited to kick off its end-of-year Cruise for its top producers. Stemtech is thrilled to be sailing the South Caribbean on the Royal Caribbean Rhapsody of the Seas, which began on Saturday, December 9^th through the 16^th with its top global leaders who earned the opportunity by qualifying for an incentive contest which began in June 2023. Stemtech looks forward to seeing this number continue to grow substantially in the coming years as more IBPs strive for excellence and qualify for this exceptional reward. Qualification for the cruise is a testament to the dedication and outstanding performance of IBPs, emphasizing Stemtech's commitment to recognizing and rewarding excellence within its community.

Qualifying IBPs showcase exceptional dedication and achievement within the Stemtech community, and the cruise serves as a symbol of appreciation for their outstanding contributions. We will also share key new 2024 initiatives with these top leaders.

In Conclusion:

Stemtech's re-entry into the Colombian market, planned product line expansion in Ecuador featuring StemFlo Advanced and MigraStem, the exciting pre-registration opportunity for IBPs, and the celebration of top producers underscore the company's commitment to international growth and the well-being of its community. These strategic initiatives position Stemtech strategically to capitalize on emerging opportunities, making 2024 a year of significant expansion and impact for the company.

ABOUT STEMTECH

Stemtech Corporation, a leading stemceutical company with a direct sales distribution model, was founded on April 18, 2018, after acquiring the operations from its predecessor Stemtech International, Inc., which was established in 2005. From 2010 through 2015, Stemtech International, Inc., was recognized four separate times on the Inc. 5000 Fastest-Growing Companies list. In 2018, Stemtech underwent an extensive executive reorganization, and continued operations under new leadership as Stemtech Corporation. In August 2021, Stemtech became a publicly traded company (OTCQB:STEK) and has expanded business opportunities for its Independent Business Partners, who may earn incomes by sharing Stemtech products. January 2022 saw the introduction of new marketing efforts. In September 2022, the new Stemtech AdvanceOffice mobile app based on the VERB Technology platform was successfully launched as a powerful communication - recruiting tool for our Field On November 1, 2022, Stemtech introduced the new travel/sample size OraStem Toothpaste. On December 6, Stemtech announced the promotion of Alejandro Carrillo to the role of Vice President Global Sales from his current role as Managing Director Latin Markets. Stemtech introduced the new CellectOne Rapid Renew Stem Cell Peptide Night Cream at their December 2022 International Leadership Event in Cancun, Mexico. January 10, 2023. Stemtech appoints Margie and Mike Mares to Field Advisory Board. Stemtech has Ranked Number 11 in Momentum out of 700+ top Global MLM companies by Business For Home independent MLM publication, January 23, 2023. Stemtech conducted Field Leadership Business Academies in Aguas Calientes, Mexico May 25 - 27, and in Las Vegas, NV on June 1 - 3. Stemtech rewards top Field Leaders with reward cruise in the South Caribbean December 9 - 16 2023 aboard the Royal Caribbean Rhapsody of the Seas.